TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure. February 1, 2002
TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011
